Evaluation of Natural killer activated receptor NKG2D, Inhibitory receptor KIR2DL1 and soluble ligand MICA in Iraqi patients of Acute myeloid leukemia. Journal of Pharmaceutical Negative Results, [S. l.], v. 13, p. 148–155, 2022. DOI: 10.47750/pnr.2022.13.S05.21. Disponível em: https://mail.pnrjournal.com/index.php/home/article/view/1761.. Acesso em: 9 jun. 2026.